Francesco Cucco

Cambridge, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 29 publications

MYC and Metabolomics: Can We Use What We Know for DLBCL Subtyping and Diagnosis?

MYC and Metabolomics: Can We Use What We Know for DLBCL Subtyping and Diagnosis?

Journal: Biomolecules

Published: July 28, 2025

Mutation profiling in differential diagnosis between TdT-positive high-grade/large B-cell lymphoma and B-lymphoblastic leukaemia/lymphoma.

Mutation profiling in differential diagnosis between TdT-positive high-grade/large B-cell lymphoma and B-lymphoblastic leukaemia/lymphoma.

Journal: The Journal of pathology

Published: April 18, 2025

MYC Point Mutations in Cancer: A Reboot and a Sequel.

MYC Point Mutations in Cancer: A Reboot and a Sequel.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: March 14, 2025

Progressive TP53 inactivation in an aggressive splenic diffuse red pulp small B-cell lymphoma.

Progressive TP53 inactivation in an aggressive splenic diffuse red pulp small B-cell lymphoma.

Journal: Leukemia & lymphoma

Published: March 22, 2024

Modified Cas9-Guided Oxford Nanopore Technology Sequencing Uncovers Single and Multiple Transgene Insertion Sites in a Zebrafish Melanoma Model.

Modified Cas9-Guided Oxford Nanopore Technology Sequencing Uncovers Single and Multiple Transgene Insertion Sites in a Zebrafish Melanoma Model.

Journal: The CRISPR journal

Published: December 18, 2023

Non-IG::MYC in diffuse large B-cell lymphoma confers variable genomic configurations and MYC transactivation potential.

Non-IG::MYC in diffuse large B-cell lymphoma confers variable genomic configurations and MYC transactivation potential.

Journal: Leukemia

Published: September 26, 2023

Relapses in early-stage follicular lymphoma frequently develop via a divergent evolution from their clonally related precursor cells.

Relapses in early-stage follicular lymphoma frequently develop via a divergent evolution from their clonally related precursor cells.

Journal: The Journal of pathology

Published: May 24, 2023

Comparison of MHG and DZsig reveals shared biology and a core overlap group with inferior prognosis in DLBCL.

Comparison of MHG and DZsig reveals shared biology and a core overlap group with inferior prognosis in DLBCL.

Journal: Blood advances

Published: May 08, 2023

Differential Efficacy From the Addition of Bortezomib to R-CHOP in Diffuse Large B-Cell Lymphoma According to the Molecular Subgroup in the REMoDL-B Study With a 5-Year Follow-Up.

Differential Efficacy From the Addition of Bortezomib to R-CHOP in Diffuse Large B-Cell Lymphoma According to the Molecular Subgroup in the REMoDL-B Study With a 5-Year Follow-Up.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: March 27, 2023

Differential impact of BRAFV600E isoforms on tumorigenesis in a zebrafish model of melanoma.

Differential impact of BRAFV600E isoforms on tumorigenesis in a zebrafish model of melanoma.

Journal: Cell & bioscience

Published: February 25, 2023

Divergent evolution of metachronous follicular lymphoma and extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue from a common precursor.

Divergent evolution of metachronous follicular lymphoma and extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue from a common precursor.

Journal: The Journal of pathology

Published: January 27, 2023

In situ follicular neoplasia in a young post-liver transplant patient.

In situ follicular neoplasia in a young post-liver transplant patient.

Journal: Pathology international

Published: September 12, 2022

Showing 1-12 of 29

Last Updated: 09/26/2026